"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 40 | 16 | 56 |
1996 | 35 | 22 | 57 |
1997 | 52 | 24 | 76 |
1998 | 34 | 17 | 51 |
1999 | 43 | 18 | 61 |
2000 | 36 | 17 | 53 |
2001 | 60 | 20 | 80 |
2002 | 62 | 35 | 97 |
2003 | 82 | 28 | 110 |
2004 | 96 | 38 | 134 |
2005 | 100 | 41 | 141 |
2006 | 111 | 26 | 137 |
2007 | 135 | 28 | 163 |
2008 | 122 | 30 | 152 |
2009 | 126 | 31 | 157 |
2010 | 145 | 38 | 183 |
2011 | 169 | 39 | 208 |
2012 | 207 | 32 | 239 |
2013 | 218 | 38 | 256 |
2014 | 227 | 36 | 263 |
2015 | 257 | 36 | 293 |
2016 | 253 | 38 | 291 |
2017 | 257 | 39 | 296 |
2018 | 272 | 38 | 310 |
2019 | 257 | 31 | 288 |
2020 | 242 | 25 | 267 |
2021 | 280 | 26 | 306 |
2022 | 264 | 5 | 269 |
2023 | 258 | 6 | 264 |
2024 | 229 | 23 | 252 |
2025 | 6 | 1 | 7 |
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Robotic-Assisted Bronchoscopy for the Diagnosis of Lung Lesions: Experience With the Use of Frozen Sections as an Aid to Confirm the Localization of Lesions During the Procedure. Arch Pathol Lab Med. 2025 Mar 01; 149(3):288-292.
-
Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics. Nat Commun. 2025 Mar 01; 16(1):2090.
-
Intravital imaging of pulmonary lymphatics in inflammation and metastatic cancer. J Exp Med. 2025 May 05; 222(5).
-
Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG). Jpn J Clin Oncol. 2025 Feb 04; 55(2):176-182.
-
The X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma. Genes (Basel). 2025 Jan 11; 16(1).
-
Targeting PRMT1 Reduces Cancer Persistence and Tumor Relapse in EGFR- and KRAS-Mutant Lung Cancer. Cancer Res Commun. 2025 Jan 01; 5(1):119-127.
-
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025. J Natl Compr Canc Netw. 2025 01; 23(1).
-
Stage at diagnosis and cancer-specific survival for stomach, lung, colorectal, and bladder cancers among Armenians in California. Prev Med. 2025 Feb; 191:108214.
-
Improving PD-1 blockade plus chemotherapy for complete remission of lung cancer by nanoPDLIM2. Elife. 2024 Dec 24; 12.
-
Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia. Thorac Cancer. 2025 Jan; 16(2):e15503.